Nayak et al. reported that HIST1H2BL, along with 21 other histone variants, were significantly over-expressed in recurrent breast tumours (aromatase inhibitor-resistant) compared with the controls [15]. The gene discussed is CYP19A1; the disease is breast neoplasm.